Please use this identifier to cite or link to this item: https://hdl.handle.net/1822/73256

Full metadata record
DC FieldValueLanguage
dc.contributor.authorVieira, Joana Margarida Pereirapor
dc.contributor.authorGranja, Sara Costapor
dc.contributor.authorMatos, Ana Catarina Barbosapor
dc.contributor.authorKo, Youngpor
dc.contributor.authorPreto, Anapor
dc.contributor.authorQueirós, Odíliapor
dc.contributor.authorCasal, Margaridapor
dc.contributor.authorBaltazar, Fátimapor
dc.date.accessioned2021-06-01T16:27:07Z-
dc.date.available2021-06-01T16:27:07Z-
dc.date.issued2019-
dc.identifier.urihttps://hdl.handle.net/1822/73256-
dc.description.sponsorshipSingle Cause Single Cure Foundationpor
dc.language.isoengpor
dc.rightsopenAccesspor
dc.title3-Bromopyruvate pre-treatment sensitizes MOLM13 and KG-1 cell lines to chemotherapypor
dc.typeconferencePosterpor
dc.peerreviewedyespor
oaire.citationConferenceDate17 Oct.-19 Oct. 2019por
sdum.event.titleCancer Metabolic Rewiring: Mapping The Road To Clinical Translation, 6th Annual ISCaM Meeting 2019por
sdum.event.typecongresspor
oaire.citationConferencePlaceBraga, Portugalpor
dc.subject.fosCiências Médicas::Ciências da Saúdepor
Appears in Collections:ICVS - Resumos em livros de atas / Abstracts in proceedings

Files in This Item:
File Description SizeFormat 
ISCaM_Final_web.pdf178,22 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID